ARTICLE | Clinical News
OraLease orally administered: started Phase I trials
September 27, 1993 7:00 AM UTC
Alkermes Inc. (ALKS) Product: OraLease orally administered, microencapsulation form of desmopressin acetate (dDAVP), an FDA-approved anti-diuretic hormone currently administered intranasally or by in...